Remission in Children Receiving Biologic Therapy for Severe Asthma.
作者信息
Bruce Eilidh, Chua Yi Cheau, Shanthikumar Shivanthan
机构信息
Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.
Respiratory Diseases, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
出版信息
Pediatr Pulmonol. 2025 Aug;60(8):e71240. doi: 10.1002/ppul.71240.
Abstract
摘要
相似文献
1
Remission in Children Receiving Biologic Therapy for Severe Asthma.接受生物疗法治疗重度哮喘的儿童的病情缓解情况。
Pediatr Pulmonol. 2025 Aug;60(8):e71240. doi: 10.1002/ppul.71240.
2
Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies.接受生物疗法治疗的重度哮喘患者的临床反应与缓解情况。
Chest. 2024 Feb;165(2):253-266. doi: 10.1016/j.chest.2023.10.046. Epub 2023 Nov 3.
3
Biologic treatment discontinuation in severe asthma: A real-life study on factors influencing clinical remission and physician decision-making.重度哮喘患者生物治疗的停药情况：一项关于影响临床缓解及医生决策因素的真实病例研究
Allergy Asthma Proc. 2025 Jul 1;46(4):287-295. doi: 10.2500/aap.2025.46.250023.
4
Is Biologic Therapy an Effective Tool for Achieving Remission in Severe Asthma? A Retrospective Study in Central Romania.生物疗法是实现重度哮喘缓解的有效工具吗？罗马尼亚中部的一项回顾性研究。
Life (Basel). 2025 Jul 16;15(7):1113. doi: 10.3390/life15071113.
5
XALOC-1: Clinical Remission Over 2 Years With Benralizumab in Severe Eosinophilic Asthma.XALOC-1：使用贝那利珠单抗治疗重度嗜酸性粒细胞性哮喘两年实现临床缓解
Chest. 2025 Jul;168(1):19-32. doi: 10.1016/j.chest.2025.04.011. Epub 2025 Apr 19.
6
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma.生物疗法对重度哮喘患者工作能力和劳动力依附的影响。
J Asthma. 2025 Jul;62(7):1246-1256. doi: 10.1080/02770903.2025.2472356. Epub 2025 Mar 5.
7
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南（2024年版）]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
8
Real-World Outcomes of Biologic Therapy for Severe Asthma in a High-Burden Urban Population.高负担城市人群中重度哮喘生物治疗的真实世界结局
Cureus. 2025 Jul 25;17(7):e88756. doi: 10.7759/cureus.88756. eCollection 2025 Jul.
9
Achieving remission in severe asthma.实现重度哮喘的缓解
Chin Med J Pulm Crit Care Med. 2025 Jun 13;3(2):77-87. doi: 10.1016/j.pccm.2025.05.001. eCollection 2025 Jun.
10
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register.使用度普利尤单抗治疗重度哮喘患者的临床反应与缓解情况：来自丹麦全国重度哮喘登记处的结果
Respir Med. 2025 Aug-Sep;245:108203. doi: 10.1016/j.rmed.2025.108203. Epub 2025 Jun 11.
本文引用的文献
1
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.探索成人接受生物治疗后重度哮喘临床缓解的定义和预测因素。
Am J Respir Crit Care Med. 2024 Oct 1;210(7):869-880. doi: 10.1164/rccm.202311-2192OC.
2
Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials.用于重度哮喘的生物制剂：随机对照试验的系统评价和荟萃分析
Eur Respir Rev. 2024 Apr 24;33(172). doi: 10.1183/16000617.0238-2023. Print 2024 Apr 30.
3
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatment.美国过敏、哮喘与免疫学会、美国过敏、哮喘与免疫学会以及美国胸科学会工作组关于哮喘治疗中临床缓解定义的共识。
Ann Allergy Asthma Immunol. 2023 Dec;131(6):782-785. doi: 10.1016/j.anai.2023.08.609. Epub 2023 Sep 8.
4
A Race-neutral Approach to the Interpretation of Lung Function Measurements.一种不基于种族的解读肺功能测量的方法。
Am J Respir Crit Care Med. 2023 Mar 15;207(6):768-774. doi: 10.1164/rccm.202205-0963OC.
5
Spectrum of asthma in children. I. Clinical and physiological components.儿童哮喘的范围。I. 临床和生理组成部分。
Br Med J. 1973 Oct 6;4(5883):7-11. doi: 10.1136/bmj.4.5883.7.
Zotero 插件